Specialty-trained pathologists more likely to make higher-grade diagnoses for melanocytic lesionsNovember 10, 2023MelanomaOncology
These adverse events linked to improved cancer prognosisSeptember 28, 2023MelanomaLung CancerOncologyMixed Topics
Impact of Socioeconomic Disparities and Facility Type on Overall Survival in Stage I vs Stage IV Amelanotic Melanoma: An Analysis of the National Cancer DatabaseSeptember 10, 2023Melanoma
Clinical Impact of UV Mutational Signatures in Veterans With CancerSeptember 10, 2023OncologyHead & Neck/Thyroid CancersLung CancerMelanoma
Do AI chatbots give reliable answers on cancer? Yes and noSeptember 1, 2023Breast CancerLung CancerGenitourinary CancerMelanomaProstate Cancer
No benefit to adding limited radiation in advanced cancerJuly 11, 2023Lung CancerMelanomaGenitourinary CancerHead & Neck/Thyroid Cancers
Cancer Data Trends 2023July 5, 2023Breast CancerGenitourinary CancerLung CancerProstate CancerColon and RectalMelanoma
Multiprong strategy makes clinical trials less WhiteJune 23, 2023Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMelanomaAML
CBSM phone app eases anxiety, depression in cancer patientsJune 23, 2023Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Huge underuse of germline testing for cancer patientsJune 22, 2023Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
